Ocular myasthenia gravis induced by human acetylcholine receptor ε subunit immunization in HLA DR3 transgenic mice

Keyphrases

• Immunization 100%
• Transgenic Mice 100%
• Ocular Myasthenia Gravis 100%
• Acetylcholine Receptor Subunit 100%
• Human Leukocyte Antigen 100%
• Myasthenia Gravis 60%
• Acetylcholine Receptor (AChR) 40%
• Experimental Autoimmune Myasthenia Gravis 30%
• Extraocular muscles 30%
• Immunopathology 20%
• Freund Incomplete Adjuvant 20%
• Acetylcholine Receptor Antibody 20%
• Human Leukocyte Antigen Class II 20%
• E. Coli Extract 20%
• Escherichia Coli 10%
• Muscle Weakness 10%
• Proliferative Response 10%
• Autoimmune Response 10%
• Clinical Course 10%
• Neuromuscular Junction 10%
• Recombinant Human 10%
• Myasthenic 10%
• Antibody IgG 10%
• IgG1 10%
• Severity Score 10%
• Lymph Node Cells 10%
• IgG2b 10%
• IgG2c 10%
• Ocular Symptoms 10%
• Low Grip Strength 10%
• Muscle Symptoms 10%
• Strength Value 10%
• Class II Allele 10%

Immunology and Microbiology

• Myasthenia gravis 100%
• Transgenic Mouse 100%
• Ocular Myasthenia 100%
• Human Leukocyte Antigen 100%
• Acetylcholine 100%
• Escherichia coli 25%
• Experimental Autoimmune Myasthenia Gravis 25%
• Extraocular Muscle 25%
• Cholinergic Receptor Antibody 16%
• Freund's Adjuvant 16%
• Autoimmunity 8%
• Allele 8%
• Immunoglobulin M 8%
• Neuromuscular Junction 8%
• Complement Deposition 8%
• Immunoglobulin G1 8%
• Lymph Node Cell 8%
• Immunoglobulin G2b 8%
• Grip Strength 8%
• Muscle 8%